In contrast, one study confirmed that RPS25 is a therapeutic target for neurodegenerative diseases caused by nucleotide repeat amplification, which indirectly confirms the role of RPS25 in the pathophysiological process of AD (Yamada et al., 2019). The gene discussed is RPS25; the disease is Alzheimer disease.